Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARRIS - Another partner -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (257)	11/23/1997 3:34:00 PM
From: biopicker	Read Replies (1) \| Respond to of 353

In response to your question, what I meant by maximizing shareholder value is that Walker is interested in building a world-class drug-development company. Sometimes that means sacrificing in the short-term to build for the long-term. In my opinion, that is precisely what has happened here. Arris is a much stronger and sounder company today than it was two or three years ago, and although the market fluctuates day to day, over the long-term, value will be recognized. Thus, I sympathize with those who are owners at higher prices, but the company is getting fundamentally stronger, and this will be reflected in the market. Cheers!